Year in Review: Rheumatoid Arthritis

(MedPage Today) -- The therapeutic options for rheumatoid arthritis (RA) continued to expand in 2020, with clinical reports emerging since the approval of the oral Janus kinase (JAK) upadacitinib (Rinvoq) for RA in August 2019. Other promising...